MarketCapTrends
TXG

10x Genomics Inc.

NASDAQ · Healthcare

10x Genomics Inc. annual/quarterly revenue history and growth rate from 2017 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.

  • 10x Genomics Inc. revenue for the quarter ending March 31, 2026 was 150.8 M, a 2.61% decrease year-over-year.
  • 10x Genomics Inc. revenue for the twelve months ending March 31, 2026 was 627.6 M, a 4.71% increase year-over-year.
  • 10x Genomics Inc. annual revenue for 2025 was 642.8 M, a 5.25% increase from 2024.
  • 10x Genomics Inc. annual revenue for 2024 was 610.8 M, a 1.28% decrease from 2023.
  • 10x Genomics Inc. annual revenue for 2023 was 618.7 M, a 19.81% increase from 2022.
  • 10x Genomics Inc. annual revenue for 2022 was 516.4 M.
Revenue
TRAILING 12 MONTHS · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %